Foundry Partners, LLC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$3,078,000
-13.2%
75,450
-3.7%
0.10%
-27.3%
Q4 2020$3,547,000
+32.7%
78,380
+3.8%
0.14%
+7.8%
Q3 2020$2,672,000
-5.9%
75,495
+0.3%
0.13%
-7.2%
Q2 2020$2,841,000
+54.6%
75,305
+18.5%
0.14%
+33.7%
Q1 2020$1,838,000
+42.4%
63,570
+155.4%
0.10%
+112.2%
Q4 2019$1,291,000
-40.6%
24,890
-37.2%
0.05%
-45.6%
Q3 2019$2,174,000
-2.6%
39,615
-27.9%
0.09%
+2.3%
Q2 2019$2,231,000
+33.2%
54,915
-0.9%
0.09%
+31.3%
Q1 2019$1,675,000
-60.5%
55,390
-50.4%
0.07%
-23.0%
Q4 2018$4,240,000
+78.2%
111,755
+98.1%
0.09%
-3.3%
Q3 2018$2,380,00056,4150.09%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders